Antibiotic susceptibility and molecular epidemiology of nasopharyngeal pneumococci from Spanish children

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
David Sánchez-TatayIgnacio Obando

Abstract

Nasopharyngeal pneumococci were collected from 635 Spanish children aged 6 months to 6 years attending four primary healthcare centres (n = 276) or two hospital emergency rooms (n = 359); 36% of the children had received >/=1 dose of pneumococcal conjugate vaccine (PCV7). Overall, the carriage rate of Streptococcus pneumoniae was 31%, with no significant differences in carriage rates according to setting. Colonization with vaccine serotypes was significantly associated with the absence of PCV7 immunization (29.4% vs. 5.9%, p <0.001). Forty-seven per cent of all isolates were penicillin- and/or erythromycin-non-susceptible; 13 international antibiotic-resistant clones were represented among non-susceptible pneumococci and were similarly distributed among vaccine and non-vaccine serotypes.

References

Dec 30, 1999·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B LópezF J Méndez
Jan 31, 2003·The Journal of Antimicrobial Chemotherapy·A FenollJ Casal
Feb 15, 2003·The Pediatric Infectious Disease Journal·Katherine L O'BrienUNKNOWN World Health Organization Pneumococcal Vaccine Trials Carriage Working Group
Sep 27, 2003·International Journal of Antimicrobial Agents·Roman PallaresUNKNOWN Spanish Pneumococcal Infection Study Network
May 25, 2004·Antimicrobial Agents and Chemotherapy·L TemimeP Y Boëlle
Apr 28, 2005·Antimicrobial Agents and Chemotherapy·Emilio Pérez-TralleroUNKNOWN Spanish Surveillance Group for Respiratory Pathogens
Apr 7, 2006·The New England Journal of Medicine·Moe H KyawUNKNOWN Active Bacterial Core Surveillance of the Emerging Infections Program Network
Mar 30, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·I ObandoA B Brueggemann

❮ Previous
Next ❯

Citations

Nov 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carmen ArdanuyJosefina Liñares
Jun 23, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Erin W NorcrossMary E Marquart
Jan 28, 2014·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Kei KasaharaKeiiichi Mikasa
Jul 19, 2014·Enfermedades infecciosas y microbiología clínica·Santiago Alfayate-MiguélezUNKNOWN Grupo de estudio de Enfermedades infecciosas de la comunidad autónoma de Murcia
Jun 15, 2013·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·L Martinez CamposC Calvo Rey
Aug 9, 2011·Enfermedades infecciosas y microbiología clínica·Ignacio ObandoMaría José Lirola
Mar 5, 2010·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·B Croche SantanderI Obando Santaella
Dec 3, 2014·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·S Alfayate-MiguélezUNKNOWN Grupo de estudio de Enfermedades infecciosas de la Comunidad Autónoma de Murcia
May 5, 2016·IDCases·Cheshil DixitLarry S McDaniel
Jan 27, 2015·Enfermedades infecciosas y microbiología clínica·Albert BoadaBonaventura Bolíbar
Aug 28, 2012·Diagnostic Microbiology and Infectious Disease·Susanna Hernandez-BouCarmen Muñoz-Almagro
Dec 3, 2014·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Monica LuminosUNKNOWN SP5000 study group
Mar 28, 2018·Antimicrobial Agents and Chemotherapy·Bruno CorsiniJose Yuste
Mar 24, 2016·MBio·Lance E KellerLarry S McDaniel
Mar 7, 2021·Vaccines·Julio SempereFernando González-Camacho

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Enfermedades infecciosas y microbiología clínica
Ignacio ObandoMaría José Lirola
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
B LópezF J Méndez
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
J García-de-LomasB Garijo
© 2022 Meta ULC. All rights reserved